Knowable Magazine reports 2025 faced turmoil in U.S. science amid job cuts and budget slashes, yet saw advances in gene ...
After beating leukemia once, a 7-year-old Ohio boy is fighting it again, and the lights outside his hospital window have ...
Some chose the stories that had the most impact, or affected them the most. Others described articles that were just plain ...
To sum up, GH001 has shown us pretty robust efficacy, a strong safety profile, and durable antidepressant effects. Going into ...
ArriVent BioPharma's furmonertinib demonstrates robust efficacy, CNS penetration, and tolerability in early trials. Read why ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback